Literature DB >> 32653335

Deep endometriosis: The place of laparoscopic shaving.

Olivier Donnez1, Jacques Donnez2.   

Abstract

Deep endometriosis (DE) is considered to be one of the most challenging conditions to manage, especially when it invades surrounding organs like the rectum. Surgical excision of deep rectovaginal endometriosis is required when lesions are symptomatic, impairing bowel, urinary, sexual, and reproductive functions, or if they evolve. Preoperative radiological examination should be extensive to determine the appropriate surgery: laparoscopic shaving, disc excision, or rectal resection. We demonstrated that in the hands of experienced surgeons, rectal shaving is possible for DE in more than 95% of cases, with low complication rates compared to rectal resection. Shaving and bowel resection are associated with comparable recurrence rates. As shaving is indicated whatever the size of deep lesions, surgeons should first consider rectal shaving to remove DE. Bowel resection should only be performed in case of major rectal stenosis (>80%), multiple and/or posterior rectal lesions and stenotic sigmoid colon lesions.
Copyright © 2020. Published by Elsevier Ltd.

Entities:  

Keywords:  Complications; Deep endometriosis; Recurrence; Shaving; Surgery; Surgical outcomes

Mesh:

Year:  2020        PMID: 32653335     DOI: 10.1016/j.bpobgyn.2020.05.006

Source DB:  PubMed          Journal:  Best Pract Res Clin Obstet Gynaecol        ISSN: 1521-6934            Impact factor:   5.237


  2 in total

Review 1.  GnRH Antagonists with or without Add-Back Therapy: A New Alternative in the Management of Endometriosis?

Authors:  Jacques Donnez; Marie-Madeleine Dolmans
Journal:  Int J Mol Sci       Date:  2021-10-20       Impact factor: 5.923

2.  Treatment preferences for medication or surgery in patients with deep endometriosis and bowel involvement - a discrete choice experiment.

Authors:  Jeroen Metzemaekers; M Elske van den Akker-van Marle; Jonathan Sampat; Mathilde J G H Smeets; James English; Elke Thijs; Jacques W M Maas; Frank Willem Jansen; Brigitte Essers
Journal:  BJOG       Date:  2021-12-27       Impact factor: 7.331

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.